PSORIASISPoster 43Long-Term Efficacy of Continuous Risankizumab in Psoriasis by Body Region: An Updated Integrated Analysis From the LIMMitless Open-Label...
PSORIASISPoster 44Risankizumab Efficacy for Moderate-to-Severe Plaque Psoriasis over 256 Weeks in Patients with Prior Biologic Treatments Authors: Jeffrey...
PSORIASISPoster 45Apremilast in Patients with Moderate-to-Severe Genital Psoriasis: Efficacy Results in the Overall Population and Body Surface Area...